Pediatricians say Pfizers vaccine data for kids 5 to 11 is a positive step forward
Pfizer's clinial trial data show a smaller dose of its vaccine is safe and effective in children ages 5 to 11 and generated a "robust" antibody response. "If we can protect more ch…